Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Drug Metabolism And Disposition

• Publication date

  1998-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9660844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topical anti-inflammatory activity of the glucocorticoid budesonide on airway mucosa. Evidence for a “hit and run” type of activity

  2005cited by this paper
• HIT AND RUN

  1999cited by this paper
• Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro.

  1998cited by this paper
• Matching scientific with societal interests: charges for the new editor.

  1998cited by this paper
• Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes.

  1997influential reference
• Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo.

  1997cited by this paper
• Cell number and distribution in human and rat airways.

  1994cited by this paper
• Binding kinetics of fluticasone propionate to the human glucocorticoid receptor.

  1994influential reference
• Total Deposition of Fluorescent Monodisperse Particles in Rats

  1994influential reference
• Relationship between lung tissue and blood plasma concentrations of inhaled budesonide.

  1993cited by this paper
• Methodological studies on lung deposition : evaluation of inhalation devices and absorption mechanisms

  1993cited by this paper
• Efficacy and Safety of Inhaled Corticosteroids in Asthma

  1993cited by this paper
• Selective aerosol delivery to intubated rats; a comparison with nose only exposure

  1992cited by this paper
• Steroidal fatty acid esters.

  1991influential reference
• A comparison of the fatty acid esters of estradiol and corticosterone synthesized by tissues of the rat.

  1989influential reference
• Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study.

  1988cited by this paper
• Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.

  1984cited by this paper
• Species differences in aerosol deposition.

  1975cited by this paper

• Intratracheal Budesonide and Bronchopulmonary Dysplasia in Extremely Preterm Infants-Reply.

  2025cites this paper
• The Modulation of Cell Plasticity by Budesonide: Beyond the Metabolic and Anti-Inflammatory Actions of Glucocorticoids

  2025cites this paper
• Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

  2025cites this paper
• Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta‐Analysis

  2025cites this paper
• The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC)

  2025cites this paper
• Inhaled budesonide and pulmonary sarcoidosis revisited

  2024cites this paper
• Poly(malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration

  2024cites this paper
• Budenoside aqueous nasal spray: an updated reappraisal in rhinitis management.

  2024cites this paper
• Budenoside aqueous nasal spray: an updated review in managing chronic rhinosinusitis with nasal polyps.

  2024cites this paper
• Budesonide Attains Its Wide Clinical Profile by Alternative Kinetics

  2024cites this paper
• Expert panel consensus recommendations on the utilization of nebulized budesonide for managing asthma and COPD in both stable and exacerbation stages in Thailand

  2024cites this paper
• Effect of budesonide on pulmonary activity of multidrug resistance-associated protein 1 assessed with PET imaging in rats.

  2023cites this paper
• Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial

  2023cites this paper
• Aerosol technology to mimic dry powder inhalation in vitro using pulmonary cell models.

  2023cites this paper
• Pharmacotherapy of BPD: Current status & future perspectives.

  2023cites this paper
• Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review

  2023cites this paper
• Practical recommendations for home-nebulized corticosteroid use in children aged ≤ 5 years with asthma: A review and advisory group consensus.

  2023cites this paper
• Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model

  2022cites this paper
• Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review

  2022cites this paper
• Comparison of Intratracheal Administration of Surfactant With or Without Budesonide to Prevent Bronchopulmonary Dysplasia: A Parallel Randomized Pilot Study

  2022cites this paper
• Developing inhaled drugs for respiratory diseases: a medicinal chemistry perspective.

  2021cites this paper
• A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome.

  2021cites this paper
• Budesonide associated with exogenous pulmonary surfactant in a novel formulation to improve the delivery to the lung.

  2021cites this paper
• Consideration of the Unbound Drug Concentration in Enzyme Kinetics.

  2021cites this paper
• Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging

  2021cites this paper
• The efficacy of intra-tracheal budesonide with surfactant in treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia

  2021cites this paper
• Beneficial Immunomodulatory Effects of Fluticasone Propionate in Chlamydia pneumoniae-Infected Mice

  2021cites this paper
• What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility

  2021cites this paper
• Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design

  2020cites this paper
• Characterization of transforming growth factor-β1 in β2 adrenergic receptor dysfunction and signaling mechanisms in human airway smooth muscle

  2020cites this paper
• Investigation of drug dissolution and uptake from low-density DPI formulations in an impactor-integrated cell culture model.

  2020cites this paper
• Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.

  2020cites this paper
• Liquid chromatography-mass spectrometry method for the quantification of corticosteroids, β2-adrenoreceptor agonists and anticholinergics in human hair.

  2020cites this paper
• Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview

  2020cites this paper
• Development and characterization of PLA nanoparticles for pulmonary drug delivery: Co-encapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug

  2019cites this paper
• Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

  2019influential citation
• Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal.

  2019cites this paper
• Bases para la utilización de nebulizadores en atención primaria

  2019cites this paper
• Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment.

  2019cites this paper
• DEVELOPMENT AND VALIDATION OF A SEMI-PHYSIOLOGICAL PHARMACOKINETIC (PBPK) MODEL TO PREDICT SYSTEMIC AND PULMONARY EXPOSURES AFTER INTRAVENOUS, ORAL ADMINISTRATION AND PULMONARY INHALATION OF SELECTED DRUGS, BUDESONIDE, TOBRAMYCIN AND CIPROFLOXACIN, IN HUMANS

  2018cites this paper
• Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation

  2018cites this paper
• Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells.

  2018cites this paper
• A Review on the Safety and Efficacy of Inhaled Corticosteroids in the Management of Asthma

  2017cites this paper
• Intratracheal Administration of Budesonide‐Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta‐Analysis

  2017cites this paper
• Behavior of thin liquid films from aqueous solutions of a pulmonary surfactant in presence of corticosteroids

  2017cites this paper
• Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.

  2017cites this paper
• Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

  2017cites this paper
• Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

  2017cites this paper
• Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials.

  2016cites this paper
• Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice.

  2016cites this paper
• Antiinflammatory Effects of Budesonide in Human Fetal Lung.

  2016cites this paper
• Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.

  2016cites this paper
• Budesonide and fluticasone propionate differentially affect the airway epithelial barrier

  2016cites this paper
• Cost–utility analysis of once-daily versus twice-daily inhaled corticosteroid dosing for maintenance treatment of asthma in pediatric patients

  2016cites this paper
• Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.

  2016cites this paper
• The development and characterization of theophylline and budesonide co-encapsulated poly (lactic acid) (PLA) nanoparticles

  2016cites this paper
• Title Antiinflammatory Effects of Budesonide in Human Fetal Lung Permalink

  2016cites this paper
• Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.

  2016cites this paper
• Chemoprevention studies within lung cancer screening programmes

  2015cites this paper
• The effect of budesonide on orthodontic induced root resorption

  2015cites this paper
• Pharmacometrics in Pulmonary Diseases

  2014cites this paper
• Current Perspectives on the Contribution of Inhaled Corticosteroids to an Increased Risk for Diabetes Onset and Progression in Patients with Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Consideration of the unbound drug concentration in enzyme kinetics.

  2014cites this paper
• Inhalational Steroids and Iatrogenic Cushing’s Syndrome

  2014cites this paper
• Intratracheal budesonide supplementation in addition to surfactant improves pulmonary outcome in surfactant‐depleted newborn piglets

  2013cites this paper
• Effect of Inhaled Corticosteroid on CT-derived Lung Density in an in vivo Allergic Inflammation Model

  2012cites this paper
• Pharmacological Factors that Influence the Choice of Inhaled Corticosteroids

  2012cites this paper
• Budesonide Therapy in Preterm Infants to Prevent Bronchopulmonary Dysplasia

  2012cites this paper
• How the Lung Handles Drugs

  2012cites this paper
• Retention of Flunisolide in Rat Lungs after Single Inhalation

  2012cites this paper
• UNIVERSITY OF LJUBLJANA FACULTY OF PHARMACY TINA OBERSKI HYDROXYPROPYL-β- CYCLODEXTRIN/CICLESONIDE COMPLEXES FOR INHALATION POWDERS

  2012cites this paper
• Rapid nongenomic actions of inhaled corticosteroids on long-acting β(2)-agonist transport in the airway.

  2011influential citation
• A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants.

  2010cites this paper
• Astma łagodna – od patogenezy do leczenia

  2009cites this paper
• In Vitro Models of the Tracheo-Bronchial Epithelium

  2008cites this paper
• [Pharmacological properties and clinical effects of the inhaled corticosteroid ciclesonide (Alvesco inhaler) for treatment of asthma].

  2008cites this paper
• Evidence of the in vivo esterification of budesonide in human airways.

  2008cites this paper
• The Biochemistry of Drug Metabolism – An Introduction

  2008cites this paper
• Review: Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma

  2008cites this paper
• Modeling and simulation of systemic and inhaled corticosteroid therapy

  2008cites this paper
• Inflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids

  2008cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Early Intratracheal Instillation of Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants: A Pilot Study

  2008cites this paper
• Feste Kombination aus Budesonid und Formoterol in der Erhaltungs- und Bedarfstherapie

  2008cites this paper
• Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations

  2007cites this paper
• Safety of inhaled corticosteroids: room for improvement.

  2007cites this paper
• In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices

  2007cites this paper
• Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide

  2007cites this paper
• A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.

  2007cites this paper
• In vitro activation of the corticosteroid ciclesonide in animal nasal mucosal homogenates

  2007cites this paper
• Laser‐ablated nanofunctional polymers for the formulation of slow‐release powders for dry powder inhalers: physicochemical characterization and slow‐release characteristics

  2007cites this paper
• Differences in Endogenous Esterification and Retention in the Rat Trachea between Budesonide and Ciclesonide Active Metabolite

  2007influential citation
• Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma

  2007cites this paper
• Similar Efficacy of Ciclesonide Once Daily Versus Fluticasone Propionate Twice Daily in Patients with Persistent Asthma

  2007cites this paper
• How to prevent relapse after acute exacerbation of asthma?

  2007cites this paper
• Ciclesonide: a new inhaled corticosteroid with improved pharmacologic characteristics

  2007cites this paper
• Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma

  2007cites this paper
• Budesonide / formoterol as an inhaler for basic therapy and relief of asthma symptoms (SMART strategy)

  2007cites this paper
• Ciclesonide is more effective than budesonide in the treatment of persistent asthma.

  2007cites this paper
• Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.

  2006cites this paper